Environments
Testing
SARS-CoV-2 B.1.1.529 (Omicron) Variant Airborne Neutralization Test
The PuriFi Labs device demonstrated a 92% total airborne reduction of SARS-CoV-2 B.1.1.529 (Omicron) Variant in 29 minutes, with a progressive reduction of 99.998% in 59 minutes.
SARS-CoV-2 B.1.617.2 (Delta) Variant Airborne Neutralization Test
The PuriFi Labs device demonstrated a 95% total airborne reduction of SARS-CoV-2 B.1.617.2 (Delta) Variant in 29 minutes, with a progressive reduction of 99.999% in 59 minutes.
SARS-CoV-2 B.1.617.2 (Delta) Variant Airborne Neutralization Test
Under real-world test conditions, AMP technology by PuriFi inactivates tested airborne SARS-CoV-2 B.1.617.2 (Delta) Variant.
SARS-CoV-2 Airborne Neutralization Test
The PuriFi Labs device demonstrated a 97.51% total reduction of SARS-CoV-2 in 29 minutes.
SARS-CoV-2 Airborne Neutralization Test
PuriFi AMP technology neutralizes tested envelope virus SARS-CoV-2 in real-world conditions for central HVAC systems.
EPA’s First Round of Test Method Development Research
Air handler unit equipped with PuriFi, operating at 350 CFM, and no air filter, achieved 99% total neutralization within 60 minutes (Total neutralization includes effects from PuriFi, air flow, and natural decay)
SARS-CoV-2 Surface Neutralization Test
Test results prove consistent SARS-CoV-2 deactivation rates of ≥ 3.23% per minute, achieving 99.994% viral inactivation within minutes.
Coronavirus Aerosol Surrogate Neutralization Test
The testing, shown on page 10 in paragraph 2, represents two different test results. The first test in the graph introduces the surrogate virus into the room and turns on the IONaer 7000 (PuriFi) at the same time, resulting in a 99.82% reduction in 33 minutes. The second test allowed the IONaer 7000 (PuriFi) to run for 10 minutes, then introduced the virus into the room, resulting in a 99.994% reduction within 10 minutes.
EPA Designed Aerobiology Chamber for Coronavirus Surrogates
Document indicates the size of the room in which the tests were performed. The size would be equal to a typical hospital room.
University of Arizona Efficacy Testing on Pathogens and Microbials
Depicts the results on E. coli, A. baummanii (mold), S. aureus (Staph), and non-enveloped viral surrogate Norovirus MS2.